By vgreene, 22 May, 2015 Address urgent conditions (eg, suicidality, acts/behaviors w/ potential to injure the adolescent or others, such as severe temper outbursts or child abuse) immediately w/ services capable of handling crisis situations
By vgreene, 22 May, 2015 Assess pts for substance abuse sx; address urgent conditions (eg, suicidality, acts/behaviors w/ potential to injure the adolescent or others, such as severe temper outbursts or child abuse) immediately w/ services capable of handling crisis situations; s
By vgreene, 22 May, 2015 Consider prescribing meds w/ no abuse potential<sup>32</sup> or stimulants w/ less abuse potential<sup>33</sup>
By vgreene, 22 May, 2015 Diversion of ADHD meds is a concern—whether by adolescents or individuals w/ close contact—and warrants monitoring sx and refill requests
By vgreene, 22 May, 2015 Ensure medication coverage for sx control for times when adolescent may exhibit risky behaviors such as driving or spending unsupervised time w/ friends:
By vgreene, 22 May, 2015 Consider longer-acting meds or late-afternoon admin of nonstimulant meds or short-acting meds
By vgreene, 22 May, 2015 Prescribe FDA-approved ADHD med w/ pt consent [A/S] and evidence-based training interventions and/or behavioral tx [A/S], preferably both
By vgreene, 22 May, 2015 If sx do not improve: Re-eval to confirm dx and/or provide education to improve adherence; reconsider tx plan: Change med/dose,<sup>30</sup> add med approved for adjuvant tx,<sup>31</sup> and/or change behavioral tx
By vgreene, 22 May, 2015 Monitor improvement in core sx3/target goals in objective way whenever possible w/ 1 of the DSM-5-based ADHD rating scales
